Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer
Clinical trial NCT04304781 · TERMINATED
Trial details
- NCT number
- NCT04304781
- Sponsor
- Danielle Kim Turgeon
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2021-12-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.